Literature DB >> 19751103

Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study.

Jesper Hjortnaes1, Danielle Gottlieb, Jose-Luiz Figueiredo, Juan Melero-Martin, Rainer H Kohler, Joyce Bischoff, Ralph Weissleder, John E Mayer, Elena Aikawa.   

Abstract

OBJECTIVES: Creating functional small-diameter tissue-engineered blood vessels has not been successful to date. Moreover, the processes underlying the in vivo remodeling of these grafts and the fate of cells seeded onto scaffolds remain unclear. Here we addressed these unmet scientific needs by using intravital molecular imaging to monitor the development of tissue-engineered vascular grafts (TEVG) implanted in mouse carotid artery. METHODS AND
RESULTS: Green fluorescent protein-labeled human bone marrow-derived mesenchymal stem cells and cord blood-derived endothelial progenitor cells were seeded on polyglycolic acid-poly-L-lactic acid scaffolds to construct small-caliber TEVG that were subsequently implanted in the carotid artery position of nude mice (n = 9). Mice were injected with near-infrared agents and imaged using intravital fluorescence microscope at 0, 7, and 35 days to validate in vivo the TEVG remodeling capability (Prosense680; VisEn, Woburn, MA) and patency (Angiosense750; VisEn). Imaging coregistered strong proteolytic activity and blood flow through anastomoses at both 7 and 35 days postimplantation. In addition, image analyses showed green fluorescent protein signal produced from mesenchymal stem cell up to 35 days postimplantation. Comprehensive correlative histopathological analyses corroborated intravital imaging findings.
CONCLUSIONS: Multispectral imaging offers simultaneous characterization of in vivo remodeling enzyme activity, functionality, and cell fate of viable small-caliber TEVG.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19751103     DOI: 10.1089/ten.TEC.2009.0466

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  13 in total

Review 1.  Cell-seeding techniques in vascular tissue engineering.

Authors:  Gustavo A Villalona; Brooks Udelsman; Daniel R Duncan; Edward McGillicuddy; Rajendra F Sawh-Martinez; Narutoshi Hibino; Christopher Painter; Tamar Mirensky; Benjamin Erickson; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part B Rev       Date:  2010-06       Impact factor: 6.389

2.  Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model.

Authors:  Mitchel R Stacy; Yuji Naito; Mark W Maxfield; Hirotsugu Kurobe; Shuhei Tara; Chung Chan; Kevin A Rocco; Toshiharu Shinoka; Albert J Sinusas; Christopher K Breuer
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-21       Impact factor: 5.209

3.  A cautionary tale for autologous vascular tissue engineering: impact of human demographics on the ability of adipose-derived mesenchymal stem cells to recruit and differentiate into smooth muscle cells.

Authors:  Jeffrey T Krawiec; Justin S Weinbaum; Claudette M St Croix; Julie A Phillippi; Simon C Watkins; J Peter Rubin; David A Vorp
Journal:  Tissue Eng Part A       Date:  2014-09-16       Impact factor: 3.845

Review 4.  Visualizing novel concepts of cardiovascular calcification.

Authors:  Jesper Hjortnaes; Sophie E P New; Elena Aikawa
Journal:  Trends Cardiovasc Med       Date:  2013-01-03       Impact factor: 6.677

5.  Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI.

Authors:  Jamie K Harrington; Halima Chahboune; Jason M Criscione; Alice Y Li; Narutoshi Hibino; Tai Yi; Gustavo A Villalona; Serge Kobsa; Dane Meijas; Daniel R Duncan; Lesley Devine; Xenophon Papademetri; Toshiharu Shin'oka; Tarek M Fahmy; Christopher K Breuer
Journal:  FASEB J       Date:  2011-08-16       Impact factor: 5.191

6.  Constructing a heparin-modified penile decellularized scaffold to improve re-endothelialization in organizational reconstruction.

Authors:  Houliang Zhang; Xinran Song; Jinliang Ni; Weipu Mao; Changxiu Tian; Jinbo Xie; Yifan Zhang; Yidi Wang; Jian Wan; Keyi Wang; Bo Peng
Journal:  Transl Androl Urol       Date:  2022-05

7.  eNOS transfection of adipose-derived stem cells yields bioactive nitric oxide production and improved results in vascular tissue engineering.

Authors:  Stephen McIlhenny; Ping Zhang; Thomas Tulenko; Jason Comeau; Sarah Fernandez; Aleksandra Policha; Matthew Ferroni; Elizabeth Faul; Gabor Bagameri; Irving Shapiro; Paul DiMuzio
Journal:  J Tissue Eng Regen Med       Date:  2013-01-14       Impact factor: 3.963

8.  Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges.

Authors:  Vivek A Kumar; Luke P Brewster; Jeffrey M Caves; Elliot L Chaikof
Journal:  Cardiovasc Eng Technol       Date:  2011-09-01       Impact factor: 2.495

Review 9.  Towards clinical application of tissue engineering for erectile penile regeneration.

Authors:  Tom W Andrew; Muholan Kanapathy; Log Murugesan; Asif Muneer; Deepak Kalaskar; Anthony Atala
Journal:  Nat Rev Urol       Date:  2019-10-24       Impact factor: 14.432

10.  Sphingosine-1-phosphate promotes the differentiation of adipose-derived stem cells into endothelial nitric oxide synthase (eNOS) expressing endothelial-like cells.

Authors:  Divya Arya; Shaohua Chang; Paul DiMuzio; Jeffrey Carpenter; Thomas N Tulenko
Journal:  J Biomed Sci       Date:  2014-06-04       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.